Lonza Group, CH0013841017

Lonza Group stock hits a 52-week high on August 21

Published on 08/24/2026 at 09:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Lonza Group stock reached a new 52-week high on August 21, 2026, with the chart signal marking CHF 591.80. That level follows a 3-month gain of 18.42 percent and gives the shares a fresh technical anchor.

Aquarell der Walliser Alpen mit Industriestandort im Tal, weiche Bergkette im Morgenlicht
Lonza CH0013841017 Aquarell der Walliser Alpen mit Industrie Standort Visp im Tal, Illustration mit AI erstellt.

Lonza Group stock reached a new 52-week high on August 21, 2026, when a chart scan marked the shares at CHF 591.80 (ISIN CH0013841017). The signal also showed a 3-month performance of 18.42 percent, giving the move a clear technical backdrop.

Chart momentum

The new high came through in a live signal list that tracked the stock at CHF 591.80 on August 21, 2026. That matters because the same table put the 3-month performance at 18.42 percent, a concrete comparison that shows the move has been building for weeks.

For investors, the key point is simple: the share price is already trading at a level that had not been reached in the prior 52 weeks. That puts the market's focus on whether the uptrend can hold after such a fast stretch.

Sector backdrop

The broader health care sector also had support in recent market commentary on August 24, 2026, which noted renewed strength in several health care names as equities were buffeted by higher oil prices and bond-market pressure. Lonza sits in that same broad defensive-growth lane, so the chart signal arrives in a sector context that has not been hostile to quality names.

A second number stands out. The same August 24, 2026 market note said the 30-year US Treasury yield briefly closed above 5.30 percent before ending the week at 5.27 percent, a reminder that valuation-sensitive shares have had to trade through higher rate pressure.

Product focus

Lonza's appeal is tied to contract development and manufacturing, where its cell and gene therapy, biologics, and small-molecule capabilities support customer pipelines across pharma and biotech. That business mix gives the group exposure to long-cycle demand rather than a single consumer product.

Price anchor

The stock was last shown at CHF 591.80 on August 21, 2026, with the fresh chart signal pointing to a 52-week breakout. The 18.42 percent 3-month rise leaves the move well documented even without adding any unsupported market color.

Fact box

Company: Lonza Group AG

ISIN: CH0013841017

Ticker: LONN

Exchange: SIX Swiss Exchange

Price (as of August 21, 2026): CHF 591.80

Sector / Industry: Health Care / Life Sciences Tools & Services

Index membership: SMI

More on Lonza Group stock

Lonza Group stock now has a clearly defined chart level at CHF 591.80, and the 18.42 percent 3-month performance gives investors a concrete reference point for the current trend.

Disclaimer...

en | CH0013841017 | LONZA GROUP | boerse | 69991858 | bgmi